Heimbach et al., 1972 - Google Patents
Effect of atropine on the tachycardia of hyperthyroidismHeimbach et al., 1972
- Document ID
- 4049355542297855406
- Author
- Heimbach D
- Crout J
- Publication year
- Publication venue
- Archives of Internal Medicine
External Links
Snippet
Dose-response curves for the effect of atropine sulfate on heart rate were determined in six hyperthyroid and six euthyroid subjects. Both groups responded to atropine in a qualitatively similar manner, but a smaller increase in heart rate was produced by atropine in the …
- 206010020850 Hyperthyroidism 0 title abstract description 35
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gaffney et al. | Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure | |
| Heimbach et al. | Effect of atropine on the tachycardia of hyperthyroidism | |
| Franceschi et al. | Effects of long‐term antiepileptic therapy on the hypothalamic‐pituitary axis in man | |
| Zelis et al. | How much can we expect from vasodilator therapy in congestive heart failure? | |
| WU et al. | The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism | |
| Anthony et al. | Controlled trials of cimetidine in migraine and cluster headache | |
| Hughes et al. | Primary neurogenic orthostatic hypotension | |
| Cooper et al. | Effects of bretylium and guanethidine on human hand and forearm vessels and on their sensitivity to noradrenaline | |
| Grimson et al. | A new orally active quaternary ammonium, ganglion blocking drug capable of reducing blood pressure, SU-3088 | |
| Kollai et al. | Reduced cardiac vagal excitability in hyperthyroidism | |
| Persson et al. | Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®) | |
| Fewings et al. | The effects of bethanidine on the peripheral circulation in man | |
| Ferguson et al. | Regulation of sympathetic nerve activity in humans: New concepts regarding autonomic adjustments to exercise and neurohumoral excitation in heart failure | |
| Caruso et al. | Pharmacology of sodium fluoride | |
| Oosterlinck et al. | Preliminary clinical experience with meptazinol, a new analgesic | |
| Davis et al. | The Surgical Problem of Hypertension | |
| Friedman | Headache—Pharmacological Approach to Treatment | |
| Given et al. | Symptomatic hypotension following the clonidine suppression test for pheochromocytoma | |
| Man in´ t Veld et al. | Patients with Congenital Dopamine β-Hydroxylase Deficiency: A Lesson in Catecholamine Physiology | |
| Channabasavanna et al. | Akathisia during lithium prophylaxis | |
| ANDERSON et al. | The effects of atropine, prostigmin, adrenaline and calcium on the movements of the fasting human stomach | |
| Fife et al. | Treatment of Hypertension in Out-Patients: The Initial Assessment, and the Effect of Reserpine | |
| Williams | Autonomic neuropathy in diabetics: a review | |
| Buxton | The problem of thyroid crisis | |
| Krstić | Analysis of the cardiovascular responses to McN-A-343 and DMPP in pithed guinea-pigs |